CMS Issues Final Payment Decision for Exact Sciences' Cologuard Test | GenomeWeb

NEW YORK (GenomeWeb) – The Centers for Medicare & Medicaid Services has issued its final payment decision for Exact Sciences' Cologuard test and will reimburse providers $502 per test, the firm announced today.

It is the exact reimbursement price the Madison, Wis.-based molecular diagnostics firm had proposed to CMS, discounted from the list price of $600.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.